{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:17:53Z","timestamp":1791047873710,"version":"4.1.0"},"reference-count":102,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1405,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1111\/j.1365-2796.2011.02455.x","type":"journal-article","created":{"date-parts":[[2011,9,19]],"date-time":"2011-09-19T17:51:47Z","timestamp":1316454707000},"page":"520-531","source":"Crossref","is-referenced-by-count":16,"title":["Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance"],"prefix":"10.1111","volume":"270","author":[{"given":"E. M.","family":"Feny\u00f6","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Esbj\u00f6rnsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Medstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,10,27]]},"reference":[{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(86)90169-8","article-title":"Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection","volume":"2","author":"Asjo","year":"1986","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.6189183","article-title":"Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)","volume":"220","author":"Barre-Sinoussi","year":"1983","journal-title":"Science"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.2832945","article-title":"Biologic features of HIV-1 that correlate with virulence in the host","volume":"240","author":"Cheng-Mayer","year":"1988","journal-title":"Science"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1128\/JVI.62.11.4414-4419.1988","article-title":"Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates","volume":"62","author":"Fenyo","year":"1988","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1128\/JVI.62.6.2026-2032.1988","article-title":"Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex","volume":"62","author":"Tersmette","year":"1988","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1128\/JVI.63.5.2118-2125.1989","article-title":"Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates","volume":"63","author":"Tersmette","year":"1989","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00002030-199201000-00006","article-title":"HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay","volume":"6","author":"Koot","year":"1992","journal-title":"Aids"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.272.5263.872","article-title":"HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor","volume":"272","author":"Feng","year":"1996","journal-title":"Science"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/381667a0","article-title":"HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5","volume":"381","author":"Dragic","year":"1996","journal-title":"Nature"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/381661a0","article-title":"Identification of a major co-receptor for primary isolates of HIV-1","volume":"381","author":"Deng","year":"1996","journal-title":"Nature"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1126\/science.272.5270.1955","article-title":"CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1","volume":"272","author":"Alkhatib","year":"1996","journal-title":"Science"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0092-8674(00)81313-6","article-title":"The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates","volume":"85","author":"Choe","year":"1996","journal-title":"Cell"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02786321","article-title":"Chemokine receptors as fusion cofactors for human immunodeficiency virus type 1 (HIV-1)","volume":"16","author":"Doranz","year":"1997","journal-title":"Immunol Res"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB14|cit14","first-page":"157","article-title":"The role of vius biological phenotype in Human Immunodeficiency Virus pathogenesis","volume":"3","author":"Feny\u00f6","year":"2001","journal-title":"AIDS Rev"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/34571","article-title":"A new classification for HIV-1","volume":"391","author":"Berger","year":"1998","journal-title":"Nature"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1128\/JVI.71.10.7478-7487.1997","article-title":"Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype","volume":"71","author":"Bjorndal","year":"1997","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/nm1197-1259","article-title":"In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression","volume":"3","author":"Scarlatti","year":"1997","journal-title":"Nat Med"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/viro.2000.0807","article-title":"Coreceptor choice and T cell depletion by R5, X4, and R5X4 HIV-1 variants in CCR5-deficient (CCR5delta32) and normal human lymphoid tissue","volume":"281","author":"Malkevitch","year":"2001","journal-title":"Virology"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1073\/pnas.94.5.1925","article-title":"The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes","volume":"94","author":"Bleul","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0065-2776(08)60910-4","article-title":"Chemokines and their receptors in lymphocyte traffic and HIV infection","volume":"74","author":"Loetscher","year":"2000","journal-title":"Adv Immunol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1126\/science.270.5243.1811","article-title":"Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8\u2003+\u2003 T cells","volume":"270","author":"Cocchi","year":"1995","journal-title":"Science"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.1101160","article-title":"The influence of CCL3L1 gene-containing segmental duplications on HIV-1\/AIDS susceptibility","volume":"307","author":"Gonzalez","year":"2005","journal-title":"Science"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2796.2008.02041.x","article-title":"Genetic correlates of protection against HIV infection: the ally within","volume":"265","author":"Piacentini","year":"2009","journal-title":"J Intern Med"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB24|cit24","first-page":"164","article-title":"Clarifying the role of G protein signaling in HIV infection: new approaches to an old question","volume":"12","author":"Juno","year":"2010","journal-title":"AIDS Rev"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.cell.2008.06.036","article-title":"HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells","volume":"134","author":"Yoder","year":"2008","journal-title":"Cell"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1742-4690-5-95","article-title":"Cofilin activation in peripheral CD4 T cells of HIV-1 infected patients: a pilot study","volume":"5","author":"Wu","year":"2008","journal-title":"Retrovirology"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"e1000520","DOI":"10.1371\/journal.ppat.1000520","article-title":"Chemokine coreceptor signaling in HIV-1 infection and pathogenesis","volume":"5","author":"Wu","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/JCM.32.2.364-370.1994","article-title":"MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection","volume":"32","author":"Karlsson","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.7326\/0003-4819-118-9-199305010-00004","article-title":"Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4\u2003+\u2003 cell depletion and progression to AIDS","volume":"118","author":"Koot","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/infdis\/169.5.968","article-title":"The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression","volume":"169","author":"Richman","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1084\/jem.185.4.621","article-title":"Change in coreceptor use correlates with disease progression in HIV-1--infected individuals","volume":"185","author":"Connor","year":"1997","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/00002030-199509000-00016","article-title":"Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men","volume":"9","author":"Spijkerman","year":"1995","journal-title":"Aids"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/viro.1997.8980","article-title":"Differences in chemokine coreceptor usage between genetic subtypes of HIV-1","volume":"241","author":"Tscherning","year":"1998","journal-title":"Virology"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/383768a0","article-title":"HIV-1 subtype and second-receptor use","volume":"383","author":"Zhang","year":"1996","journal-title":"Nature"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1056\/NEJMc086373","article-title":"The challenge of HIV-1 subtype diversity","volume":"359","author":"Taylor","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1097\/00002030-199907300-00006","article-title":"HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS","volume":"13","author":"Abebe","year":"1999","journal-title":"Aids"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/088922299310944","article-title":"Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients","volume":"15","author":"Bjorndal","year":"1999","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1128\/JVI.77.7.4449-4456.2003","article-title":"The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C","volume":"77","author":"Cilliers","year":"2003","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/QAI.0b013e3180385aa0","article-title":"Relation between chemokine receptor use, disease stage, and HIV-1 subtypes A and D: results from a rural Ugandan cohort","volume":"45","author":"Kaleebu","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1128\/JVI.69.8.4649-4655.1995","article-title":"Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in northern Thailand","volume":"69","author":"Yu","year":"1995","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/QAD.0b013e3282f57f7a","article-title":"Emergence of X4 usage among HIV-1 subtype C: evidence for an evolving epidemic in South Africa","volume":"22","author":"Connell","year":"2008","journal-title":"Aids"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.tim.2005.04.005","article-title":"The HIV coreceptor switch: a population dynamical perspective","volume":"13","author":"Regoes","year":"2005","journal-title":"Trends Microbiol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0966-842X(02)02370-3","article-title":"Cell turnover and cell tropism in HIV-1 infection","volume":"10","author":"Davenport","year":"2002","journal-title":"Trends Microbiol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1182\/blood.V95.1.249","article-title":"T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART)","volume":"95","author":"Hazenberg","year":"2000","journal-title":"Blood"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1128\/JVI.01295-06","article-title":"Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch","volume":"81","author":"Mild","year":"2007","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1128\/JVI.78.10.5205-5215.2004","article-title":"The V1\/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection","volume":"78","author":"Pinter","year":"2004","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/088922200309412","article-title":"Occurrence of additional NF-kappaB-binding motifs in the long terminal repeat region of South African HIV type 1 subtype C isolates","volume":"16","author":"Hunt","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1089\/08892220152644232","article-title":"Characterization of full-length HIV type 1 subtype C sequences from South Africa","volume":"17","author":"van Harmelen","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1128\/JVI.77.2.1021-1038.2003","article-title":"Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C","volume":"77","author":"Ball","year":"2003","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB50|cit50","first-page":"75","article-title":"HIV diversity, recombination and disease progression: how does fitness \u201cfit\u201d into the puzzle?","volume":"9","author":"Tebit","year":"2007","journal-title":"AIDS Review"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/QAI.0b013e3181f63906","article-title":"Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C","volume":"56","author":"Coetzer","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/jmv.20572","article-title":"Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G","volume":"78","author":"Konings","year":"2006","journal-title":"J Med Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1742-4690-3-40","article-title":"The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness","volume":"3","author":"Njai","year":"2006","journal-title":"Retrovirology"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"9006","DOI":"10.1128\/JVI.79.14.9006-9018.2005","article-title":"Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression","volume":"79","author":"Troyer","year":"2005","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/nm.2203","article-title":"Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level","volume":"16","author":"Bunnik","year":"2010","journal-title":"Nat Med"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nature07746","article-title":"Adaptation of HIV-1 to human leukocyte antigen class I","volume":"458","author":"Kawashima","year":"2009","journal-title":"Nature"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-4690-7-23","article-title":"Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease - indication of an evolving epidemic in West Africa","volume":"7","author":"Esbjornsson","year":"2010","journal-title":"Retrovirology"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"9222","DOI":"10.1128\/JVI.74.19.9222-9233.2000","article-title":"A dual infection\/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression","volume":"74","author":"Quinones-Mateu","year":"2000","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"10489","DOI":"10.1128\/JVI.73.12.10489-10502.1999","article-title":"Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection","volume":"73","author":"Shankarappa","year":"1999","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1086\/314987","article-title":"Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression","volume":"180","author":"de Roda Husman","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB61|cit61","first-page":"325","article-title":"Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS","volume":"2","author":"Jansson","year":"1999","journal-title":"J Hum Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1742-4690-5-28","article-title":"Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression","volume":"5","author":"Borggren","year":"2008","journal-title":"Retrovirology"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.virol.2005.04.034","article-title":"Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome","volume":"337","author":"Gray","year":"2005","journal-title":"Virology"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"15382","DOI":"10.1073\/pnas.93.26.15382","article-title":"Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates","volume":"93","author":"Jansson","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"11807","DOI":"10.1128\/JVI.78.21.11807-11815.2004","article-title":"Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype","volume":"78","author":"Karlsson","year":"2004","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1086\/377105","article-title":"Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection","volume":"188","author":"Koning","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/374650","article-title":"Increased in vitro cytopathicity of CC chemokine receptor 5-restricted human immunodeficiency virus type 1 primary isolates correlates with a progressive clinical course of infection","volume":"187","author":"Kwa","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.meegid.2009.05.003","article-title":"Differences in molecular evolution between switch (R5 to R5X4\/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection","volume":"10","author":"Mild","year":"2010","journal-title":"Infect Genet Evol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1099\/vir.0.81111-0","article-title":"Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency","volume":"86","author":"Repits","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.virol.2008.06.014","article-title":"Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge","volume":"379","author":"Repits","year":"2008","journal-title":"Virology"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1742-4690-4-89","article-title":"Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS","volume":"4","author":"Sterjovski","year":"2007","journal-title":"Retrovirology"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.virol.2010.05.006","article-title":"An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes","volume":"404","author":"Sterjovski","year":"2010","journal-title":"Virology"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.virol.2009.10.029","article-title":"Enhanced CD4\u2003+\u2003 cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection","volume":"396","author":"Wade","year":"2010","journal-title":"Virology"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2217\/fvl.10.34","article-title":"Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis","volume":"5","author":"Duenas-Decamp","year":"2010","journal-title":"Future Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"11151","DOI":"10.1128\/JVI.79.17.11151-11160.2005","article-title":"Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue","volume":"79","author":"Karlsson","year":"2005","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1097\/00002030-200312050-00004","article-title":"Molecular mapping of epitopes for interaction of HIV-1 as well as natural ligands with the chemokine receptors, CCR5 and CXCR4","volume":"17","author":"Antonsson","year":"2003","journal-title":"Aids"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1097\/00002030-200312050-00003","article-title":"HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use","volume":"17","author":"Karlsson","year":"2003","journal-title":"Aids"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1521-4141(200001)30:1<164::AID-IMMU164>3.0.CO;2-X","article-title":"Molecular modeling and site-directed mutagenesis of CCR5 reveal residues critical for chemokine binding and signal transduction","volume":"30","author":"Zhou","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1097\/QAD.0b013e32833d7d8c","article-title":"Flexible use of CCR5 in the absence of CXCR4 use explains the immune deficiency in HIV-1 infected children","volume":"24","author":"Cavarelli","year":"2010","journal-title":"Aids"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"e3292","DOI":"10.1371\/journal.pone.0003292","article-title":"HIV-1 with multiple CCR5\/CXCR4 chimeric receptor use is predictive of immunological failure in infected children","volume":"3","author":"Cavarelli","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1089\/aid.2009.0069","article-title":"Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates","volume":"25","author":"Karlsson","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"e20135","DOI":"10.1371\/journal.pone.0020135","article-title":"Increased sensitivity to broadly neutralizing antibodies of end-stage disease R5 HIV-1 correlates with evolution in Env glycosylation and charge","volume":"6","author":"Borggren","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"7932","DOI":"10.1128\/JVI.00757-08","article-title":"Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection","volume":"82","author":"Bunnik","year":"2008","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB84|cit84","first-page":"859","article-title":"Dendritic-cell interactions with HIV: infection and viral dissemination. Nature reviews","volume":"6","author":"Wu","year":"2006","journal-title":"Immunology"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.4049\/jimmunol.178.5.3177","article-title":"Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4\u2003+\u2003 T lymphocytes","volume":"178","author":"van Montfort","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1089\/aid.2010.0359","article-title":"Severe immune suppression in patients infected with R5-Tropic HIV-1 strains is associated with increased gp120 net charge at variable regions","volume":"27","author":"Seclen","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0006-3495(04)74197-1","article-title":"Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation","volume":"86","author":"Davis","year":"2004","journal-title":"Biophys J"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1126\/science.274.5294.1924","article-title":"Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines","volume":"274","author":"Atchison","year":"1996","journal-title":"Science"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81364-1","article-title":"Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity","volume":"87","author":"Rucker","year":"1996","journal-title":"Cell"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1128\/JVI.71.9.6305-6314.1997","article-title":"Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1","volume":"71","author":"Doranz","year":"1997","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1074\/jbc.274.14.9617","article-title":"Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function","volume":"274","author":"Lee","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1073\/pnas.94.8.4005","article-title":"Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains","volume":"94","author":"Edinger","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1124\/mol.107.042101","article-title":"Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists","volume":"73","author":"Kondru","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1086\/589289","article-title":"Reviews of anti-infective agents: maraviroc: the first of a new class of antiretroviral agents","volume":"47","author":"MacArthur","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2165\/11203940-000000000-00000","article-title":"Maraviroc: a review of its use in the management of CCR5-tropic HIV-1 infection","volume":"70","author":"Perry","year":"2010","journal-title":"Drugs"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJMoa0803154","article-title":"Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection","volume":"359","author":"Fatkenheuer","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jac\/dkq535","article-title":"Maraviroc is able to inhibit dual-R5 viruses in a dual\/mixed HIV-1-infected patient","volume":"66","author":"Symons","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/COH.0b013e3283223d46","article-title":"A piece de resistance: how HIV-1 escapes small molecule CCR5 inhibitors","volume":"4","author":"Moore","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/COH.0b013e3280142007","article-title":"Resistance to CCR5 antagonists","volume":"2","author":"Westby","year":"2007","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"e1000548","DOI":"10.1371\/journal.ppat.1000548","article-title":"Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry","volume":"5","author":"Berro","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"12151","DOI":"10.1128\/JVI.01351-09","article-title":"Structure-function analysis of human immunodeficiency virus type 1 gp120 amino acid mutations associated with resistance to the CCR5 coreceptor antagonist vicriviroc","volume":"83","author":"Ogert","year":"2009","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2796.2011.02455.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"10863","DOI":"10.1128\/JVI.01109-10","article-title":"A maraviroc-resistant HIV-1 with narrow cross-resistance to other CCR5 antagonists depends on both N-terminal and extracellular loop domains of drug-bound CCR5","volume":"84","author":"Tilton","year":"2010","journal-title":"J Virol"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.2011.02455.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2796.2011.02455.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T19:12:35Z","timestamp":1686337955000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.2011.02455.x"}},"subtitle":["Symposium: Evolution of HIV-1 coreceptor use and entry inhibitors"],"short-title":[],"issued":{"date-parts":[[2011,10,27]]},"references-count":102,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.2011.02455.x","relation":{},"ISSN":["0954-6820"],"issn-type":[{"value":"0954-6820","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10,27]]}}}